Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Change in Acquisitions & Divestments (2024 - 2025)

Historic Change in Acquisitions & Divestments for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to $3.0 million.

  • Indivior Pharmaceuticals' Change in Acquisitions & Divestments fell 9347.83% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year decrease of 6475.41%. This contributed to the annual value of $117.0 million for FY2024, which is 930.23% down from last year.
  • Per Indivior Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at $3.0 million for Q3 2025, which was down 9347.83% from $5.0 million recorded in Q2 2025.
  • Indivior Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $46.0 million during Q3 2024, with a 5-year trough of $3.0 million in Q3 2025.
  • For the 4-year period, Indivior Pharmaceuticals' Change in Acquisitions & Divestments averaged around $21.3 million, with its median value being $28.0 million (2023).
  • As far as peak fluctuations go, Indivior Pharmaceuticals' Change in Acquisitions & Divestments soared by 52000.0% in 2023, and later crashed by 9347.83% in 2025.
  • Over the past 4 years, Indivior Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $12.0 million in 2022, then soared by 183.33% to $34.0 million in 2023, then decreased by 14.71% to $29.0 million in 2024, then crashed by 89.66% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $5.0 million for Q2 2025, and $6.0 million during Q1 2025.